Дефицит железа у подростков и его коррекция препаратами железа
DOI:
https://doi.org/10.15574/67746Ключевые слова:
подростки, железодефицитное состояние, железодефицитная анемия, латентный дефицит железа, ферритин, эритроцитарные индексы, цветовой показатель, железа (III) гидроксид-полимальтозный комплекс, терапияАннотация
Диагностика и коррекция железодефицитных состояний остаются актуальной проблемой практической педиатрии. В статье представлены данные о распространенности и особенностях клинических проявлений, диагностики и лечения дефицита железа у подростков. Отмечено особое значение диеты и важность правильного выбора железосодержащего препарата для коррекции дефицита железа у подростков.
Ключевые слова: подростки, железодефицитное состояние, железодефицитная анемия, латентный дефицит железа, ферритин, эритроцитарные индексы, цветовой показатель, железа (III) гидроксид-полимальтозный комплекс, терапия.Библиографические ссылки
Feeding and nutrition of infants young children. Guidelines for the WHO European Region, with emphasis on the former Soviet countries. WHO Regional Publications, European Series, №87. WHO. 2000. Updated reprint 2003.
Baker RD, Greer FR. 2010. Committee on Nutrition American Academy of Pediatrics. Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0–3 years of age). Pediatrics. 126; 5: 1040–1050. http://dx.doi.org/10.1542/peds.2010-2576; PMid:20923825
Zhu YP, Liao QK. 2004. Collaborative Study Group for «The Epidemiological Survey of Iron Deficiency in Children in China». Prevalence of iron deficiency in children aged 7 months to 7 years in China. Zhonghua Er Ke Za Zhi. 42;12: 886—891. PMid:15733354
Corapci F, Calatroni A, Kaciroti N et al. 2010. Longitudinal evaluation of externalizing and internalizing behavior problems following iron deficiency in infancy. J Pediatr Psychol. 35; 3: 296—305. http://dx.doi.org/10.1093/jpepsy/jsp065; PMid:19736288 PMCid:PMC2842097
Zhu A, Kaneshiro M, Kaunitz JD. 2010. Evaluation and treatment of iron deficiency anemia: a gastroenterological perspective. Dig Dis Sci. 55; 3: 548—559. http://dx.doi.org/10.1007/s10620-009-1108-6; PMid:20108038 PMCid:PMC2822907
Angulo-Barroso RM, Schapiro L, Liang W et al. 2011. Motor development in 9-month-old infants in relation to cultural differences and iron status. Dev Psychobiol. 53; 2: 196—210. http://dx.doi.org/10.1002/dev.20512; PMid:21298634 PMCid:PMC3230936
Cotta RM, Oliveira F de C, Magalhaes KA et al. 2011. Social and biological determinants of iron deficiency anemia. Cad Saude Publica. 27; Suppl 2: S309—S320. http://dx.doi.org/10.1590/S0102-311X2011001400017; PMid:21789422
Hay G, Sandstad B, Whitelaw A, Borch-Iohnsen B. 2004. Iron status in a group of Norwegian children aged 6—24 months. Acta Paediatr. 93; 5: 592—598. http://dx.doi.org/10.1111/j.1651-2227.2004.tb02983.x; PMid:15174778
Benoist B, McLean E, Egli I, Cogswell M. 2008. Worldwide prevalence of anaemia, 1993—2005: WHO global database on anaemia. Geneva: WHO.
Buchanan GR. 2009. Screening for iron deficiency during early infancy: is it feasible and is it necessary? Am J Clin Nutr. 89; 2: 473—474. http://dx.doi.org/10.3945/ajcn.2008.27284; PMid:19116318
Korovina NF, Zaplatnykov AL, Zaharova IN. 1999. Zhelezodefitsitnyie anemii u detey. M: 56.
Pavlov AD, Morschakova EF, Rumyantcev AG. 2011. Eritropoez, eritropoetin, zhelezo. M, GEOTAR-Media: 304.
Anemii u detey: diagnostika, differentsialnaya diagnostika, lechenie. Pod red AG Rumyantseva, YuN Tokareva. 2-e izd, dop i pererab. M, MAKS Press. 2004: 216.
Krasilnikova MV. 2006. Zhelezodefitsitnyie sostoyaniya u podrostkov: chastotnyie harakteristiki, struktura i vtorichnaya profilaktika. Dis kand med nauk. M: 92.
Korovina NA, Zaharova IN, Svintsitskaya VI. 2006. Defitsit zheleza i kognitivnyie rasstroystva u detey. Lechaschiy vrach. 5: 69—71.
WHO/NHD. Iron deficiency anaemia. Assessment, prevention and control: a guide for programme managers. Geneva: WHO, 2001.
The World Health Report. 22. Screening for Iron Deficiency Anemia — Including Iron Prophilaxis. Recommendation. Geneva: WHO, 1998.
De Maeyer EM, Dallman P, Gurney JM et al. 1989. The prevalence of anaemia in the world. Preventing and controlling iron deficiency anaemia through primary health care: a guide for health administrators and programme managers: 5—58.1989. Geneva: WHO.
Tarasova IS, Chernov VM. 2012. Novyie napravleniya v diagnostike, lechenii i profilaktike zhelezodefitsitnyih sostoyaniy. Sovr pediatriya. 2: 18—24.
Kazyukova TV, Samsyigina GA, Levina AL. 2002.Problemyi terapii zhelezodefitsitnoy anemii u detey. Pediatriya. 6: 4—10.
Zaharova IN, Dmitrieva YuA. 2011. Korrektsiya sideropenii u detey. Vopr prakt pediatrii. 6; 2: 36—40.
Korovina NA, Zaharova IN, Zaplatnikov AL, Malova NE. 2008. Profilaktika i lechenie zhelezodefitsitnyih sostoyaniy u detey. Pediatriya. 1: 101.
Normyi fiziologicheskih potrebnostey v energii i pischevyih veschestvah dlya razlichnyih grupp naseleniya Rossiyskoy Federatsii. Metodicheskie rekomendatsii MR 2.3.1.2432 — 08 (ot 18 dekabrya 2008 goda): 41.
Idelson LI. 1981. Gipohromnyie anemii. M, Meditsina:190.
Erichsen K, Ulvik RJ, Grimstad T et al. 2005. Effects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 22; 9: 831—838. http://dx.doi.org/10.1111/j.1365-2036.2005.02652.x; PMid:16225492
Zaharova IN, Zaplatnikov AL, Malova NE. 2003. Vyibor preparatov zheleza dlya ferroterapii zhelezodefitsitnoy anemii u detey. Russkiy med zhurnal. 11;1: 38—41.
Toblli JE, Brignoli R. 2007. Iron (III)-hydroxide polymaltose complex in iron deficiency anemia. Review and metaanalysis. Arzneimittelforschung. 57; 6A: 431—438. PMid:17691593
Agaoglu L, Torun O, Unuvar E et al. 2007. Effects of iron deficiency anemia on cognitive function in children. Arzneimittelforschung. 57; 6A: 426—430. PMid:17691592
Devaki PB, Chandra RK, Geisser P. 2009. Effects of oral iron(III) hydroxide polymaltose complex supplementation on hemoglobin increase, cognitive function, affective behavior and scholastic performance of adoles-cents with varying iron status: a single centre prospective placebo controlled study. Arzneimittelforschung. 59; 6: 303—310. PMid:19634512
Geisser P, Muller A. 1987. Pharmacokinetics of iron salts and ferric hydroxide-carbohydrate complexes. Arzneimittelforschung. 37; 1A: 100—104. PMid:3566862
Instruktsiya po meditsinskomu primeneniyu preparata Maltofer.
